DE3787274T2 - Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten. - Google Patents

Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten.

Info

Publication number
DE3787274T2
DE3787274T2 DE87310882T DE3787274T DE3787274T2 DE 3787274 T2 DE3787274 T2 DE 3787274T2 DE 87310882 T DE87310882 T DE 87310882T DE 3787274 T DE3787274 T DE 3787274T DE 3787274 T2 DE3787274 T2 DE 3787274T2
Authority
DE
Germany
Prior art keywords
pyranoquinoline
aqueous solution
pharmaceutical preparations
preparations containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE87310882T
Other languages
English (en)
Other versions
DE3787274D1 (de
Inventor
Andrew Reginald Clark
Julia Helena Ratcliffe
Paul Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630767A external-priority patent/GB8630767D0/en
Priority claimed from GB868630769A external-priority patent/GB8630769D0/en
Priority claimed from GB868630904A external-priority patent/GB8630904D0/en
Priority claimed from GB878706684A external-priority patent/GB8706684D0/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of DE3787274D1 publication Critical patent/DE3787274D1/de
Application granted granted Critical
Publication of DE3787274T2 publication Critical patent/DE3787274T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DE87310882T 1986-12-23 1987-12-10 Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten. Expired - Lifetime DE3787274T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868630767A GB8630767D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB868630769A GB8630769D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB868630904A GB8630904D0 (en) 1986-12-24 1986-12-24 Pharmaceutical formulation
GB878706684A GB8706684D0 (en) 1987-03-20 1987-03-20 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
DE3787274D1 DE3787274D1 (de) 1993-10-07
DE3787274T2 true DE3787274T2 (de) 1994-01-27

Family

ID=27449862

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87310882T Expired - Lifetime DE3787274T2 (de) 1986-12-23 1987-12-10 Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten.

Country Status (22)

Country Link
US (1) US5443833A (de)
EP (1) EP0279121B1 (de)
JP (2) JP2568233B2 (de)
KR (1) KR960001370B1 (de)
AU (1) AU595969B2 (de)
BE (2) BE1002179A5 (de)
CA (1) CA1296635C (de)
CH (1) CH674937A5 (de)
DE (1) DE3787274T2 (de)
DK (1) DK175032B1 (de)
ES (1) ES2058129T3 (de)
FI (1) FI875616A (de)
FR (1) FR2609392B1 (de)
GR (1) GR871999B (de)
IE (3) IE63213B1 (de)
IL (1) IL84893A (de)
LU (1) LU87087A1 (de)
MY (1) MY101535A (de)
NO (1) NO875359L (de)
NZ (1) NZ223026A (de)
PT (1) PT86455B (de)
SA (1) SA90110074B1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
EP0294914A3 (de) * 1987-03-17 1990-10-10 FISONS plc Nedocromil zur Behandlung von dermatologischen Krankheiten
GB8727590D0 (en) * 1987-11-25 1987-12-31 Fisons Plc Formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
RU2576033C2 (ru) * 2009-12-03 2016-02-27 Опко Хелс, Инк. Составы на основе гиперсулфатированных дисахаридов

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474787A (en) * 1977-05-04 1984-10-02 Fisons Limited 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
DE3070179D1 (en) * 1979-12-07 1985-03-28 Fisons Plc A process for the production of 1,4-dihydro-4-oxo-quinoline-2-carboxylic acids, or salts, esters or amides thereof and intermediates therefor
AU8468782A (en) * 1981-06-25 1983-01-06 Fisons Plc Compounds with sodium cromoglycate activity
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
DE3584580D1 (de) * 1984-04-13 1991-12-12 Fisons Plc Formen und formulierungen des nedocromil-natriumsalzes.
GB8630419D0 (en) * 1986-12-19 1987-01-28 Fisons Plc Pharmaceutical formulation
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
EP0294914A3 (de) * 1987-03-17 1990-10-10 FISONS plc Nedocromil zur Behandlung von dermatologischen Krankheiten

Also Published As

Publication number Publication date
BE1002179A5 (fr) 1990-10-02
CA1296635C (en) 1992-03-03
SA90110074B1 (ar) 2006-03-06
JPH07231926A (ja) 1995-09-05
DK680787D0 (da) 1987-12-22
FI875616A (fi) 1988-06-24
US5443833A (en) 1995-08-22
NO875359D0 (no) 1987-12-21
GR871999B (en) 1988-04-26
IE63213B1 (en) 1995-04-05
EP0279121A3 (en) 1990-09-12
FR2609392B1 (fr) 1994-04-08
DE3787274D1 (de) 1993-10-07
IL84893A0 (en) 1988-06-30
NO875359L (no) 1988-06-24
DK175032B1 (da) 2004-05-03
EP0279121B1 (de) 1993-09-01
KR960001370B1 (ko) 1996-01-26
MY101535A (en) 1991-11-30
LU87087A1 (fr) 1989-07-07
NZ223026A (en) 1989-09-27
AU8292987A (en) 1988-06-23
JP2568233B2 (ja) 1996-12-25
PT86455B (pt) 1990-11-20
FR2609392A1 (fr) 1988-07-15
AU595969B2 (en) 1990-04-12
EP0279121A2 (de) 1988-08-24
ES2058129T3 (es) 1994-11-01
JPS63233918A (ja) 1988-09-29
IE940372L (en) 1988-06-23
IE940371L (en) 1988-06-23
DK680787A (da) 1988-06-24
CH674937A5 (de) 1990-08-15
JP2504926B2 (ja) 1996-06-05
BE1003466A3 (fr) 1992-03-31
IL84893A (en) 1991-11-21
IE873507L (en) 1988-06-23
PT86455A (en) 1988-01-01
KR880007082A (ko) 1988-08-26
FI875616A0 (fi) 1987-12-21

Similar Documents

Publication Publication Date Title
NL930061I2 (nl) Anti-fungus-middelen, werkwijze ter bereiding daarvan en farmaceutische preparaten, die deze anti-fungus-middelen bevatten.
NL950014I1 (nl) Met sulfamoyl gesubstitueerde fenetylaminederivaten, de bereiding daarvan en farmaceutische preparaten, die deze derivaten bevatten.
NL193981B (nl) 7-(eventueel gesubstitueerd naftyl)-3-methyl-octa-2,4,6-trieenderivaten met retineachtige werking alsmede farmaceutische en kosmetische preparaten die dergelijke derivaten bevatten.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
NL190552C (nl) 1-Fenyl-4-alkyl-7,8-dialkoxy-5H-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten.
NL193819B (nl) Naftaleenderivaten alsmede farmaceutische en cosmetische preparaten, die deze derivaten bevatten.
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
DE3673803D1 (de) Waessrige zubereitung von 1,2-benzisothiazolin-3-on.
NL194612B (nl) Aromatische, alkenisch onverzadigde retino´den, alsmede dergelijke verbindingen bevattende farmaceutische en cosmetische preparaten.
NL930101I2 (nl) Gebruik van 3,3'-azo-bis-(6-hydroxybenzoëzuur) alseen medicijn en farmaceutische preparaten die dez e stof bevatten.
NL194431B (nl) Farmaceutische preparaten die ranitidine bevatten.
DE3682960D1 (de) Pharmazeutische praeparate.
DE69002748T2 (de) Wässerige Lösung, die einen Ginkgo-Blätterextrakt enthält.
NL188645B (nl) 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
DE68902300T2 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DE3787274D1 (de) Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten.
ATE67210T1 (de) Androstane-17-beta-carbonsaeureester, verfahren zu deren herstellung und pharmazeutische praeparate die diese enthalten.
ATE93725T1 (de) Pharmazeutische praeparate, die eine waesserige loesung eines pyranoquinolins enthalten.
SE8501518D0 (sv) Pharmazeutische preparate
FR2603284B1 (fr) Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique
ATA313088A (de) Pharmazeutische waessrige formulierungen, die ein piperidinylcyclopentylheptensaeure-derivat enthalten
DE3774849D1 (de) Alkylaminoalkylisch oder heterocyclylalkylisch an den triazolring substituierte 8-azaxanthine, ihre physiologisch vertraeglichen salze, ihre pharmazeutische zubereitungen mit antibronchospastischer wirkung und verfahren zu ihrer herstellung.
DK454987D0 (da) 2,3-dihydro-1h-phenalen-2-aminoforbindelser eller syreadditionssalte deraf samt farmaceutiske praeparater indeholdende dem
ATE50494T1 (de) Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten.
NL174646C (nl) 6,7-dimethoxy-4-amino-2-piperidinochinazolinen en farmaceutische preparaten die ze bevatten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition